U.S. Markets closed

Report: Exploring Fundamental Drivers Behind ON Semiconductor, Pilgrim's Pride, Merck & Co., Healthcare Services Group, Genomic Health, and Spectrum Pharmaceuticals — New Horizons, Emerging Trends, and Upcoming Developments

NEW YORK, March 25, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ON Semiconductor Corporation (ON), Pilgrim's Pride Corporation (PPC), Merck & Co., Inc. (MRK), Healthcare Services Group, Inc. (HCSG), Genomic Health, Inc. (GHDX), and Spectrum Pharmaceuticals, Inc. (SPPI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ON DOWNLOAD: http://Fundamental-Markets.com/register/?so=ON
PPC DOWNLOAD: http://Fundamental-Markets.com/register/?so=PPC
MRK DOWNLOAD: http://Fundamental-Markets.com/register/?so=MRK
HCSG DOWNLOAD: http://Fundamental-Markets.com/register/?so=HCSG
GHDX DOWNLOAD: http://Fundamental-Markets.com/register/?so=GHDX
SPPI DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPPI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine ON Semiconductor Corporation (ON), Pilgrim's Pride Corporation (PPC), Merck & Co., Inc. (MRK), Healthcare Services Group, Inc. (HCSG), Genomic Health, Inc. (GHDX), and Spectrum Pharmaceuticals, Inc. (SPPI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 22nd, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ON SEMICONDUCTOR CORPORATION (ON) REPORT OVERVIEW

ON Semiconductor's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, ON Semiconductor reported revenue of $1,503.10MM vs $1,377.50MM (up 9.12%) and analysts estimated basic earnings per share $0.40 vs $1.25 (down 68.00%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, ON Semiconductor reported revenue of $5,878.30MM vs $5,543.10MM (up 6.05%) and analysts estimated basic earnings per share $1.48 vs $1.92 (down 22.92%). Analysts expect earnings to be released on April 29th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.40. The estimated EPS forecast for the next fiscal year is $2.11 and is expected to report on February 7th, 2020.

To read the full ON Semiconductor Corporation (ON) report, download it here: http://Fundamental-Markets.com/register/?so=ON

-----------------------------------------

PILGRIM'S PRIDE CORPORATION (PPC) REPORT OVERVIEW

Pilgrim's Pride's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Pilgrim's Pride reported revenue of $2,656.79MM vs $2,742.35MM (down 3.12%) and analysts estimated basic earnings per share -$0.03 vs $0.53. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Pilgrim's Pride reported revenue of $10,937.78MM vs $10,767.86MM (up 1.58%) and analysts estimated basic earnings per share $1.00 vs $2.79 (down 64.16%). Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.53. The estimated EPS forecast for the next fiscal year is $1.72 and is expected to report on February 12th, 2020.

To read the full Pilgrim's Pride Corporation (PPC) report, download it here: http://Fundamental-Markets.com/register/?so=PPC

-----------------------------------------

MERCK & CO., INC. (MRK) REPORT OVERVIEW

Merck & Co.'s Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Merck & Co. reported revenue of $10,998.00MM vs $10,433.00MM (up 5.42%) and analysts estimated basic earnings per share $0.70 vs -$0.37. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Merck & Co. reported revenue of $42,294.00MM vs $40,122.00MM (up 5.41%) and analysts estimated basic earnings per share $2.34 vs $0.88 (up 165.91%). Analysts expect earnings to be released on May 7th, 2019. The report will be for the fiscal period ending March 31st, 2019. Based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $1.03. Reported EPS for the same quarter last year was $1.05. The estimated EPS forecast for the next fiscal year is $5.16 and is expected to report on February 7th, 2020.

To read the full Merck & Co., Inc. (MRK) report, download it here: http://Fundamental-Markets.com/register/?so=MRK

-----------------------------------------

HEALTHCARE SERVICES GROUP, INC. (HCSG) REPORT OVERVIEW

Healthcare Services Group's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Healthcare Services Group reported revenue of $496.41MM vs $499.41MM (down 0.60%) and basic earnings per share $0.43 vs $0.27 (up 59.26%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Healthcare Services Group reported revenue of $2,008.82MM vs $1,866.13MM (up 7.65%) and analysts estimated basic earnings per share $1.13 vs $1.20 (down 5.83%). Analysts expect earnings to be released on April 16th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.00. The estimated EPS forecast for the next fiscal year is $1.71 and is expected to report on February 4th, 2020.

To read the full Healthcare Services Group, Inc. (HCSG) report, download it here: http://Fundamental-Markets.com/register/?so=HCSG

-----------------------------------------

GENOMIC HEALTH, INC. (GHDX) REPORT OVERVIEW

Genomic Health's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Genomic Health reported revenue of $104.61MM vs $87.46MM (up 19.60%) and analysts estimated basic earnings per share $0.26 vs $0.05 (up 420.00%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Genomic Health reported revenue of $394.11MM vs $340.75MM (up 15.66%) and analysts estimated basic earnings per share $0.72 vs -$0.11. Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $1.67 and is expected to report on February 19th, 2020.

To read the full Genomic Health, Inc. (GHDX) report, download it here: http://Fundamental-Markets.com/register/?so=GHDX

-----------------------------------------

SPECTRUM PHARMACEUTICALS, INC. (SPPI) REPORT OVERVIEW

Spectrum Pharmaceuticals' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Spectrum Pharmaceuticals reported revenue of $29.40MM vs $28.57MM (up 2.91%) and analysts estimated basic earnings per share -$0.47 vs -$0.28. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Spectrum Pharmaceuticals reported revenue of $109.33MM vs $128.37MM (down 14.83%) and analysts estimated basic earnings per share -$1.16 vs -$1.07. Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.19. The estimated EPS forecast for the next fiscal year is -$1.17 and is expected to report on February 27th, 2020.

To read the full Spectrum Pharmaceuticals, Inc. (SPPI) report, download it here: http://Fundamental-Markets.com/register/?so=SPPI

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2019 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.